-
Structural Basis of TRPM3 Modulation by Neurosteroids and Dr
2026-07-24
This study delineates the molecular mechanisms by which neurosteroids and the anticonvulsant primidone regulate the TRPM3 ion channel. High-resolution cryo-EM structures reveal ligand binding sites, clarify disease mutation impacts, and provide a foundation for targeted therapeutic development.
-
Plk1 Modulation of p31comet: Regulation of Mitotic Checkpoin
2026-07-24
This study reveals that Polo-like kinase 1 (Plk1) directly phosphorylates p31comet, inhibiting its function in mitotic checkpoint complex (MCC) disassembly. These findings clarify a key regulatory mechanism controlling the spindle assembly checkpoint, with implications for cell cycle research and the use of mitotic progression inhibitors.
-
L-NMMA Acetate: Strategic Modulation of NOS Pathways in Tran
2026-07-23
This article explores the mechanistic, strategic, and translational dimensions of L-NMMA acetate (N(G)-monomethyl-L-arginine acetate) as a precision tool for nitric oxide pathway modulation in research. Blending recent mechanistic insights from peer-reviewed studies with actionable protocol guidance and a competitive landscape analysis, we provide translational researchers with a roadmap for deploying NOS inhibitors in regenerative, inflammation, and disease modeling contexts. The discussion escalates beyond typical product summaries by integrating evidence-driven perspectives, cross-domain maturity, and forward-looking challenges in nitric oxide synthase targeting.
-
HSP90 Inhibition Destabilizes METTL3, Disrupts MYC m6A in CR
2026-07-23
This study uncovers a mechanistic link between HSP90 and the RNA methyltransferase METTL3 in colorectal cancer. Inhibition of HSP90 by 17-AAG promotes METTL3 degradation, leading to reduced m6A modification and MYC expression, with broad implications for RNA regulation in tumor progression.
-
Miltefosine Induces Neutrophil Differentiation via Ras/MEK/E
2026-07-22
This study demonstrates that Miltefosine, also known as hexadecyl 2-(trimethylazaniumyl)ethyl phosphate, promotes neutrophil differentiation and restores white blood cell counts in leukopenia models by activating the Ras/MEK/ERK pathway. These findings offer mechanistic insights that could inform future therapeutic strategies for hematological recovery.
-
DIDS: Mechanisms, Benchmarks, and Limits in Chloride Channel
2026-07-22
DIDS (4,4'-Diisothiocyanostilbene-2,2'-disulfonic Acid) is a potent chloride channel inhibitor with reproducible IC50 values for ClC-Ka and ClC-ec1. It modulates TRPV1 activity and demonstrates neuroprotective and anti-tumor effects. This dossier details atomic, verifiable benchmarks and clarifies misconceptions for advanced research workflows.
-
OSMI-1: Precision O-GlcNAc Transferase Inhibitor for Mechani
2026-07-21
OSMI-1 empowers researchers to dissect O-GlcNAcylation-mediated regulation in placental ferroptosis and syncytialization, with robust workflow control and reproducible inhibition of OGT. Its high purity and well-characterized performance facilitate advanced, data-driven O-GlcNAc research in cell and in vivo models.
-
MAPK10–KRT16 Axis Suppresses NSCLC Metastasis via Ubiquitina
2026-07-21
This study identifies mitogen-activated protein kinase 10 (MAPK10) as a key regulator of non-small cell lung cancer (NSCLC) metastasis through phosphorylation-dependent ubiquitination and degradation of keratin 16 (KRT16). The findings provide strong evidence for the MAPK10/KRT16/RNF213 pathway as a novel prognostic biomarker and therapeutic target in NSCLC, offering new directions in metastatic cancer research.
-
2-(4,5,6,7-tetrabromo...) Inhibitor: Advancing Kinase and Co
2026-07-20
Harness the CK2 and ERK8 inhibitor as a precise small molecule tool for dissecting kinase-driven phase separation and protein-protein interactions. This article provides actionable workflows, troubleshooting guidance, and insight into cross-domain applications in viral condensate biology.
-
AS1842856 Foxo1 Inhibitor: Precision Tool for Metabolic Rese
2026-07-20
AS1842856 enables targeted suppression of Foxo1 activity, unlocking new experimental avenues in gluconeogenesis and autophagy research. Its robust selectivity and validated protocols make it an indispensable asset for dissecting metabolic and stem cell signaling networks.
-
Vitamin C (CAS 50-81-7): Anticancer Mechanisms in Next-Gen O
2026-07-19
Explore the anticancer and apoptosis-inducing properties of Vitamin C (CAS 50-81-7) with advanced insight into organoid and in vivo models. This article provides a distinct, evidence-driven perspective on ascorbic acid's mechanistic action and translational relevance for cancer research.
-
Sodium Phosphate Dibasic: Optimizing Biological Assay Buffer
2026-07-18
Sodium phosphate dibasic (Na2HPO4) delivers unmatched pH stability and reproducibility in biological and aquatic toxicity assays. This article translates cutting-edge research and published best practices into actionable workflows, advanced applications, and troubleshooting insights, empowering researchers to maximize experimental reliability.
-
Fenipentol (1-Phenyl-1-pentanol): Applied Workflows & Optimi
2026-07-17
Fenipentol unlocks precision in pancreatobiliary and hepatic research, acting as both a choleretic agent and a modulator of fibrosis-linked pathways. This article details advanced experimental workflows, troubleshooting, and protocol enhancements that leverage Fenipentol’s unique bioactivity profile.
-
DHA Mitigates Inflammatory Fetal Growth Restriction in Mice
2026-07-17
This study demonstrates that maternal docosahexaenoic acid (DHA) supplementation during pregnancy effectively counteracts lipopolysaccharide (LPS)-induced intrauterine growth restriction (FGR) in fetal mice. By dissecting the molecular and microbiome-mediated mechanisms, the research highlights DHA’s modulation of placental inflammation and gut–placenta signaling as a promising nutritional intervention for inflammation-driven pregnancy complications.
-
Direct Reprogramming of Astrocytes into Motoneuron-like Cell
2026-07-16
This study demonstrates that a defined set of four transcription factors—ASCL1, MYT1L, POU3F2, and ISL1—can directly reprogram rat and human astrocytes into functionally relevant motoneuron-like cells. The findings offer a promising pathway for spinal cord injury research by enabling the generation of motor neurons from abundant glial sources.